Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0055 AUD | +10.00% | +10.00% | +10.00% |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
Mar. 05 | Invion's Anti-Cancer Drug Logs Postive Preclinical Trial Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+10.00% | 23.62M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- IVX Stock
- News Invion Limited
- Invion Partners with Hanlim Pharma for Glioblastoma Treatment